Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Human Genome Sciences receives FDA approval to begin clinical trials of BLyS

Sep. 21, 2001

Inhibitex enters into partnership with Wyeth Lederle Vaccines

Sep. 19, 2001

Recent patent covers hydroxamic acid-based inhibitors of sCD23

Sep. 17, 2001

Maxygen and InterMune to develop next-generation interferon gamma products

Sep. 10, 2001

Advanced Viral Research given clearance to move Product R into phase I clinical trials

Sep. 6, 2001

FDA issues complete response letter for FluMist BLA

Sep. 5, 2001

Immunomodulatory peptides identified by Entopharm

Sep. 4, 2001

Avax granted licensing option for SCID gene therapy technology

Aug. 29, 2001

Novel cytokine production inhibitors highlighted at the ongoing ACS meeting

Aug. 28, 2001

New series of inhibitors of TNF production may be useful as immunosuppressants

Aug. 27, 2001

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...